Accéder au contenu
Merck

Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer.

Oncotarget (2017-12-10)
Fei Song, Geng Wang, Zhifang Ma, Yuebing Ma, Yingying Wang
RÉSUMÉ

Bcl2-associated athanogene 3 (BAG3) has been reported to be involved in aggressive progression of many tumors. In the present study, we examined the expression of BAG3 in human cervical cancer (CC) tissues and investigated the role of BAG3 in SiHa and HeLa cell growth, migration, and invasion. Here, we found that most of CC tissues highly expressed the protein and mRNA of BAG3, while their expression was obviously lower in paired normal tissues (all p<0.001). BAG3 expression was associated with FIGO stage and metastasis (all p<0.05).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
MISSION® esiRNA, targeting human BAG3